Answers are grounded in this paper and cite their sources.
Mucosal barriers are not only physical; they are the source of potent antimicrobial peptides. These ancient compounds are important for the innate defense of an eukaryotic host. They function within a matter of hours, on a broad spectrum of bacteria, fungi, and encapsulated viruses (reviewed in (34, 94, 102)). The innate immune system works in conjunction with the adaptive immune system in mammals, by permitting the host to curb, delay, or avoid microbial growth shortly after an infection. For example, human -defensins, specific epithelial cell-derived antimicrobial peptides (see below), have been shown to "cross-talk" with the adaptive immune system by interacting with specific chemokine and Toll-like receptors, resulting in modulation of immunocompetent cell responses of the host It is theorized therefore, that surveillance through epithelial cell-derived antimicrobial peptides functions to keep the natural flora of microorganisms in a steady state in different niches such as the skin, the intestines, and the mouth. This review will highlight recent findings, by our group and others, demonstrating that antimicrobial peptides are not just antimicrobial; they play an added role of cross-talking with a number of cell types in functions as diverse as regulating epithelial cell proliferation, enhancing wound healing, inhibiting/inducing pro-inflammatory cytokines, promoting/inhibiting angiogenesis, stimulating chemokine production, promoting chemotaxis of various leukocytes, degranulating mast cells or modulating host cell gene expression.
No takes yet. Share an insight, caveat, or question.
McCormick et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: